Danaher Corp
Change company Symbol lookup
Select an option...
DHR Danaher Corp
SF-B Stifel Financial Corp
GSHRF Goldshore Resources Inc
GSQD G Squared Ascend I Inc
GL Globe Life Inc
MDIA Mediaco Holding Inc
SWVLW Swvl Holdings Equity Warrant Exp 31st Mar 2027 *W EXP 03/31/2027
SCBCX Franklin Multi-Asset Conservative Growth Fund C
BUI BlackRock Utilities, Infrastructure & Power Opportunities Trust
FDEU First Trust Dynamic Europe Equity Income

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

Today's volume of 3,526 shares is on pace to be much lighter than DHR's 10-day average volume of 2,580,560 shares.




6 providers
June 29, 2022
Danaher Announces Appointment of Feroz Dewan to Danaher Board

Danaher Corporation (NYSE: DHR) announced today that it has appointed Feroz Dewan to its Board of Directors and to the Board's Science & Technology Committee. This addition expands the size of Danaher's Board from thirteen to fourteen members. (PR Newswire)

June 21, 2022
Danaher Schedules Second Quarter 2022 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. (PR Newswire)

June 06, 2022
SCIEX Launches the New Cornerstone of Software Ecosystem - SCIEX OS 3.0

At ASMS 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches SCIEX OS software v3.0, a software ecosystem built on accessibility, connectivity and integration. With this...(BusinessWire)

SCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022

SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches Zeno SWATH DIA, a significant step forward in biomarker discovery and translation workflows. (BusinessWire)

May 12, 2022
Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

Consortium aims to speed the development and delivery of customized or 'bespoke' gene therapies Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate...(PR Newswire)

May 10, 2022

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common stock, payable on July 29, 2022 to holders of record on June 24, 2022. In addition, the Board...(PR Newswire)

May 09, 2022
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics

At TIDES 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches the RNA 9000 Purity & Integrity kit, for the BioPhase 8800 system and PA 800 Plus system. (BusinessWire)

May 04, 2022
Danaher To Present At Bank Of America Securities Health Care Conference

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 11, 2022 at 10:00 a.m. PT. The...(PR Newswire)

April 21, 2022
Danaher Reports First Quarter 2022 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the first quarter 2022. For the quarter ended April 1, 2022, net earnings were $1.7 billion, or $2.31 per diluted common share which represents a 1.0% increase over the...(PR Newswire)

April 12, 2022
Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock

Danaher Corporation (NYSE: DHR) announced today that its 4.75% Series A Mandatory Convertible Preferred Stock (the "Preferred Stock"), will automatically convert into shares of the Company's Common Stock on April 15, 2022 (the "Conversion Date")...(PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.